Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 5.30% and Operating profit at -10.67% over the last 5 years
2
The company has declared Negative results for the last 10 consecutive quarters
3
With ROE of 5.11%, it has a fair valuation with a 1.77 Price to Book Value
4
Market Beating Performance
Stock DNA
Chemicals & Petrochemicals
CNY 15,258 Million (Large Cap)
35.00
NA
0.61%
0.05
5.34%
2.12
Revenue and Profits:
Net Sales:
1,015 Million
(Quarterly Results - Mar 2026)
Net Profit:
115 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.49%
0%
3.49%
6 Months
20.0%
0%
20.0%
1 Year
52.71%
0%
52.71%
2 Years
39.37%
0%
39.37%
3 Years
-3.15%
0%
-3.15%
4 Years
-7.54%
0%
-7.54%
5 Years
8.88%
0%
8.88%
Valiant Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.30%
EBIT Growth (5y)
-10.67%
EBIT to Interest (avg)
30.09
Debt to EBITDA (avg)
0.22
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.46
Tax Ratio
5.91%
Dividend Payout Ratio
37.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.08%
ROE (avg)
10.52%
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
1.77
EV to EBIT
40.71
EV to EBITDA
17.10
EV to Capital Employed
1.71
EV to Sales
3.72
PEG Ratio
NA
Dividend Yield
0.74%
ROCE (Latest)
4.20%
ROE (Latest)
5.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,015.30
890.30
14.04%
Operating Profit (PBDIT) excl Other Income
130.30
109.80
18.67%
Interest
6.10
4.70
29.79%
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
114.50
-9.10
1,358.24%
Operating Profit Margin (Excl OI)
128.40%
-12.20%
14.06%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.04% vs -6.91% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,358.24% vs -107.30% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,691.30
3,642.90
1.33%
Operating Profit (PBDIT) excl Other Income
873.50
854.00
2.28%
Interest
25.50
32.30
-21.05%
Exceptional Items
-37.60
-39.30
4.33%
Consolidate Net Profit
385.70
383.20
0.65%
Operating Profit Margin (Excl OI)
111.40%
108.90%
0.25%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.33% vs -14.94% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 0.65% vs -56.54% in Dec 2024
About Valiant Co., Ltd. 
Valiant Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






